169 related articles for article (PubMed ID: 11753975)
41. Carcinoma in situ of the urinary bladder with and without associated vesical neoplasms.
Prout GR; Griffin PP; Daly JJ; Heney NM
Cancer; 1983 Aug; 52(3):524-32. PubMed ID: 6861089
[TBL] [Abstract][Full Text] [Related]
42. FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.
Swinnen G; Maes A; Pottel H; Vanneste A; Billiet I; Lesage K; Werbrouck P
Eur Urol; 2010 Apr; 57(4):641-7. PubMed ID: 19477579
[TBL] [Abstract][Full Text] [Related]
43. Preoperative radiotherapy for muscle-invasive bladder carcinoma. Long term follow-up and prognostic factors for 338 patients.
Pollack A; Zagars GK; Dinney CP; Swanson DA; von Eschenbach AC
Cancer; 1994 Nov; 74(10):2819-27. PubMed ID: 7954243
[TBL] [Abstract][Full Text] [Related]
44. Predictive value of lymphangiogenesis and proliferation markers on mRNA level in urothelial carcinoma of the bladder after radical cystectomy.
Martini T; Heinkele J; Mayr R; Weis CA; Wezel F; Wahby S; Eckstein M; Schnöller T; Breyer J; Wirtz R; Ritter M; Bolenz C; Erben P
Urol Oncol; 2018 Dec; 36(12):530.e19-530.e27. PubMed ID: 30446441
[TBL] [Abstract][Full Text] [Related]
45. Transitional cell carcinoma of the urinary bladder with regional lymph node involvement treated by cystectomy: clinicopathologic features associated with outcome.
Frank I; Cheville JC; Blute ML; Lohse CM; Nehra A; Weaver AL; Karnes RJ; Zincke H
Cancer; 2003 May; 97(10):2425-31. PubMed ID: 12733141
[TBL] [Abstract][Full Text] [Related]
46. Tumor size predicts the survival of patients with pathologic stage T2 bladder carcinoma: a critical evaluation of the depth of muscle invasion.
Cheng L; Neumann RM; Scherer BG; Weaver AL; Leibovich BC; Nehra A; Zincke H; Bostwick DG
Cancer; 1999 Jun; 85(12):2638-47. PubMed ID: 10375113
[TBL] [Abstract][Full Text] [Related]
47. Clinical Lymphadenopathy in Urothelial Cancer: A Transatlantic Collaboration on Performance of Cross-sectional Imaging and Oncologic Outcomes in Patients Treated with Radical Cystectomy Without Neoadjuvant Chemotherapy.
Moschini M; Morlacco A; Briganti A; Hu B; Colombo R; Montorsi F; Frank I; Daneshmand S; Karnes RJ
Eur Urol Focus; 2018 Mar; 4(2):245-251. PubMed ID: 28753820
[TBL] [Abstract][Full Text] [Related]
48. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
[TBL] [Abstract][Full Text] [Related]
49. The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate.
Frazier HA; Robertson JE; Dodge RK; Paulson DF
Cancer; 1993 Jun; 71(12):3993-4001. PubMed ID: 8508365
[TBL] [Abstract][Full Text] [Related]
50. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
Cho KS; Seo HK; Joung JY; Park WS; Ro JY; Han KS; Chung J; Lee KH
J Urol; 2009 Dec; 182(6):2625-30. PubMed ID: 19836779
[TBL] [Abstract][Full Text] [Related]
51. The predictors of local recurrence after radical cystectomy in patients with invasive bladder cancer.
Ide H; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
Jpn J Clin Oncol; 2008 May; 38(5):360-4. PubMed ID: 18490370
[TBL] [Abstract][Full Text] [Related]
52. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
53. Loss expression of uroplakin III is associated with clinicopathologic features of aggressive bladder cancer.
Matsumoto K; Satoh T; Irie A; Ishii J; Kuwao S; Iwamura M; Baba S
Urology; 2008 Aug; 72(2):444-9. PubMed ID: 18313120
[TBL] [Abstract][Full Text] [Related]
54. Multiple factor analysis of metachronous upper urinary tract transitional cell carcinoma after radical cystectomy.
Wang P; Luo JD; Wu WF; Wang S; Cai SL; Shen BH; Shi SF; Wei KX; Zhang ZG; Chen ZD
Braz J Med Biol Res; 2007 Jul; 40(7):979-84. PubMed ID: 17653452
[TBL] [Abstract][Full Text] [Related]
55. Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate.
Thrasher JB; Frazier HA; Robertson JE; Dodge RK; Paulson DF
Cancer; 1994 Mar; 73(6):1708-15. PubMed ID: 8156499
[TBL] [Abstract][Full Text] [Related]
56. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
Shariat SF; Bolenz C; Godoy G; Fradet Y; Ashfaq R; Karakiewicz PI; Isbarn H; Jeldres C; Rigaud J; Sagalowsky AI; Lotan Y
J Urol; 2009 Jul; 182(1):78-84; discussion 84. PubMed ID: 19447418
[TBL] [Abstract][Full Text] [Related]
57. Local control of muscle-invasive bladder cancer: preoperative radiotherapy and cystectomy versus cystectomy alone.
Cole CJ; Pollack A; Zagars GK; Dinney CP; Swanson DA; von Eschenbach AC
Int J Radiat Oncol Biol Phys; 1995 May; 32(2):331-40. PubMed ID: 7751174
[TBL] [Abstract][Full Text] [Related]
58. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE
Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431
[TBL] [Abstract][Full Text] [Related]
59. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
Steven K; Poulsen AL
J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
[TBL] [Abstract][Full Text] [Related]
60. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
